Alterations in serum opsonic activity and complement levels in pneumococcal disease.
Pneumococcal opsonic activity and concentrations of pneumococcal capsular polysaccharide antigen, C3, C4 factor B, C3 and factor B breakdown products were measured in the serum obtained acutely from 12 patients with serious pneumococcal disease. One patient showed markedly reduced pneumococcal opsonic activity, borderline-low C3, and the presence of C3 and factor B breakdown products and died. Although eight additional patients showed depressed levels of C3 or C4 or the presence of C3 or factor B breakdown products, none had reduced pneumococcal opsonic activity. All of the three remaining patients had normal opsonic activity and C3 and C4 levels. Covalescent serum was obtained from eight patients; six had normal C3 and C4 levels, and two had persistent C4 depression. These data show that complement is activated during pneumococcal disease and suggest that extensive complement activation may impair pneumococcal opsonic activity in certain patients and thereby compromise an important host defense mechanism.
D000942:Antigens, Bacterial; D003176:Complement C3 / Q000096:biosynthesis; D003181:Complement C4 / Q000096:biosynthesis; D011415:Complement Factor B / Q000096:biosynthesis; D003165:Complement System Proteins / Q000096:biosynthesis*; D006801:Humans; D009895:Opsonin Proteins / Q000276:immunology*; D011008:Pneumococcal Infections / Q000276:immunology*; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000276:immunology
D000942:Antigens, Bacterial; D003176:Complement C3; D003181:Complement C4; D009895:Opsonin Proteins; D003165:Complement System Proteins; D011415:Complement Factor B